(04-09-2021, 11:04 AM)ken-do-nim Wrote: No you're right I do, in general, prefer ETFs. But good point about the elective surgery business.Most of us lose patience at times. With blue chip DGI I try to avoid being impulsive. When in doubt I pull up a chart and and add the S&P500 as a comparison. I look at long-term return and drawdowns. I just did for JNJ. It has been equal of better to the SPY for about 18 of the last 20 years. SPY has beat it last two years. When we bought matters in the short-term view. Do I think JNJ will outperform SPY the next few years? I don't know but there is a chance. Do I think it is undervalued vs SPY, or at least less overvalued? Yes I do. Everything is relative in this game. They grow earning through thick and thin. The Div always grows. Will it drawdown less than SPY in a rough market? It almost certainly will be safer, and maybe by 10 or 20%.
I am giving MRK and PFE the same scrutiny. I've held PFE for 25yrs and it's very clearly a long-term underperformer. Only DRP made it better than a CD. MRK is only marginally better, but it seems to have more near to midterm upside. I have no justification to hold either with much confidence. I'll sell some covered calls on small runs and let the market decide. At least I'll get some income to invest elsewhere in the meantime.